59
Participants
Start Date
October 31, 2010
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
Saizen®
Single dose of Saizen® (recombinant human growth hormone, r-hGH) solution for injection will be administered subcutaneously for 26 weeks. Dosage regimen will be in accordance with marketed formulation of Saizen® (freeze-dried formulation), based on locally approved product labeling.
US Medical Information
Lead Sponsor
EMD Serono
INDUSTRY